Illumina (ILMN) and Tempus AI (TEM) announced a collaboration to accelerate clinical adoption of next-generation sequencing tests through novel ...

BofA lowered the firm’s price target on Tempus AI (TEM) to $48 from $60 and keeps a Neutral rating on the shares. Sentiment for Life Sciences ...

Companies like Tempus AI TEM are leading the charge by leveraging AI for precision medicine. The stock’s 42.9% surge year to date strongly underscores a broader market shift—highlighting the ...

Financial giants have made a conspicuous bearish move on Tempus AI. Our analysis of options history for Tempus AI TEM revealed 9 unusual trades. Delving into the details, we found 44% of traders ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

CHICAGO, March 26, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will present at the 24th Annual ...

CHICAGO, March 26, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will present at the 24th ...

We list the best calendar apps, to make it simple and easy to better organize your schedule. Whether you're running your own business or an employee, chances are there aren't enough hours in the ...

We recently published a list of 10 Stocks Lead Friday’s Charge. In this article, we are going to take a look at where Tempus AI (NASDAQ:TEM) stands against other stocks that lead Friday’s charge.